These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 27583404)
1. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial. Griffin SJ; Rutten GEHM; Khunti K; Witte DR; Lauritzen T; Sharp SJ; Dalsgaard EM; Davies MJ; Irving GJ; Vos RC; Webb DR; Wareham NJ; Sandbæk A Lancet Diabetes Endocrinol; 2019 Dec; 7(12):925-937. PubMed ID: 31748169 [TBL] [Abstract][Full Text] [Related]
3. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Griffin SJ; Borch-Johnsen K; Davies MJ; Khunti K; Rutten GE; Sandbæk A; Sharp SJ; Simmons RK; van den Donk M; Wareham NJ; Lauritzen T Lancet; 2011 Jul; 378(9786):156-67. PubMed ID: 21705063 [TBL] [Abstract][Full Text] [Related]
4. Effect of early intensive multifactorial therapy compared with routine care on self-reported health status, general well-being, diabetes-specific quality of life and treatment satisfaction in screen-detected type 2 diabetes mellitus patients (ADDITION-Europe): a cluster-randomised trial. Van den Donk M; Griffin SJ; Stellato RK; Simmons RK; Sandbæk A; Lauritzen T; Khunti K; Davies MJ; Borch-Johnsen K; Wareham NJ; Rutten GE Diabetologia; 2013 Aug; 56(11):2367-77. PubMed ID: 23959571 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Griffin SJ; Bethel MA; Holman RR; Khunti K; Wareham N; Brierley G; Davies M; Dymond A; Eichenberger R; Evans P; Gray A; Greaves C; Harrington K; Hitman G; Irving G; Lessels S; Millward A; Petrie JR; Rutter M; Sampson M; Sattar N; Sharp S Health Technol Assess; 2018 Apr; 22(18):1-64. PubMed ID: 29652246 [TBL] [Abstract][Full Text] [Related]
7. Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT. Bruce J; Hossain A; Lall R; Withers EJ; Finnegan S; Underwood M; Ji C; Bojke C; Longo R; Hulme C; Hennings S; Sheridan R; Westacott K; Ralhan S; Martin F; Davison J; Shaw F; Skelton DA; Treml J; Willett K; Lamb SE Health Technol Assess; 2021 May; 25(34):1-114. PubMed ID: 34075875 [TBL] [Abstract][Full Text] [Related]
8. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial. Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211 [TBL] [Abstract][Full Text] [Related]
9. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study. Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402 [TBL] [Abstract][Full Text] [Related]
10. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. Sandbæk A; Griffin SJ; Sharp SJ; Simmons RK; Borch-Johnsen K; Rutten GE; van den Donk M; Wareham NJ; Lauritzen T; Davies MJ; Khunti K Diabetes Care; 2014 Jul; 37(7):2015-23. PubMed ID: 24784827 [TBL] [Abstract][Full Text] [Related]
11. Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation. Mackenzie IS; Hawkey CJ; Ford I; Greenlaw N; Pigazzani F; Rogers A; Struthers AD; Begg AG; Wei L; Avery AJ; Taggar JS; Walker A; Duce SL; Barr RJ; Dumbleton JS; Rooke ED; Townend JN; Ritchie LD; MacDonald TM; Health Technol Assess; 2024 Mar; 28(18):1-55. PubMed ID: 38551218 [TBL] [Abstract][Full Text] [Related]
12. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review. Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666 [TBL] [Abstract][Full Text] [Related]
13. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial. Simmons RK; Sharp SJ; Sandbæk A; Borch-Johnsen K; Davies MJ; Khunti K; Lauritzen T; Rutten GE; van den Donk M; Wareham NJ; Griffin SJ Diabet Med; 2012 Nov; 29(11):e409-16. PubMed ID: 22823477 [TBL] [Abstract][Full Text] [Related]
14. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT. Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176 [TBL] [Abstract][Full Text] [Related]
15. A multicentre randomised controlled trial and economic evaluation of continuous positive airway pressure for the treatment of obstructive sleep apnoea syndrome in older people: PREDICT. McMillan A; Bratton DJ; Faria R; Laskawiec-Szkonter M; Griffin S; Davies RJ; Nunn AJ; Stradling JR; Riha RL; Morrell MJ Health Technol Assess; 2015 Jun; 19(40):1-188. PubMed ID: 26063688 [TBL] [Abstract][Full Text] [Related]
16. Impact of a social prescribing intervention in North East England on adults with type 2 diabetes: the SPRING_NE multimethod study. Moffatt S; Wildman J; Pollard TM; Gibson K; Wildman JM; O'Brien N; Griffith B; Morris SL; Moloney E; Jeffries J; Pearce M; Mohammed W Public Health Res (Southampt); 2023 Mar; 11(2):1-185. PubMed ID: 37254700 [TBL] [Abstract][Full Text] [Related]
17. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up. Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906 [TBL] [Abstract][Full Text] [Related]
18. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
19. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT. Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995 [TBL] [Abstract][Full Text] [Related]